Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart

Journal of Clinical Investigation

Volumn 101, Issue 11, 1998, Pages 2415-2426

  Fentzke, Richard C ^a   Korcarz, Claudia E ^a   Lang, Roberto M ^a   Lin, Hua ^a   Leiden, Jeffrey M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

cAMP responsive; Cardiovascular models; Congestive cardiomyopathy; DNA binding protein; Gene expression regulation; adrenergic receptors

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA PRESSURE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART; HEART CONTRACTION; HEART DILATATION; HEART VENTRICLE FUNCTION; HISTOPATHOLOGY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

EID: 0032102257     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2950     Document Type: Article

References (65)

1. Cohn, J.N. 1996. The management of chronic heart failure. N. Engl. J. Med. 335:490-498.
2. Massie, B.M., and M. Packer. 1990. Congestive heart failure: current controversies and future prospects. Am. J. Cardiol. 66:429-430.
3. Davies, M.J., and W.J. McKenna. 1994. Dilated cardiomyopathy: an introduction to pathology and pathogenesis. Br. Heart J. 72(Suppl.):S24.
4. Dec, G.W., and V. Fuster. 1994. Idiopathic dilated cardiomyopathy. N. Engl. J. Med. 331:1564-1575.
5. McMinn, T.R., and J. Ross. 1995. Hereditary dilated cardiomyopathy. Clin. Cardiol. 18:7-15.
6. Durand, J.-B., A.B. Abchee, and R. Roberts. 1995. Molecular and Clinical Aspects of Inherited Cardiomyopathies. Ann. Med. 27:311-317.
7. Codd, M.B., D.D. Sugrue, B.J. Gersh, and I.L.J. Melton. 1989. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population-based study in Olmsted County, Minnesota. Circulation. 80:564-572.
8. Montminy, M.R., and L.M. Bilezikjian. 1987. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature. 328: 175-178.
9. Gonzalez, G.A., K.K. Yamamoto, W.H. Fischer, D. Karr, P. Menzel, I.W. Biggs, W.W. Vale, and M.R. Montminy. 1989. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature. 337:749-752.
10. Habener, J.F. 1990. Cyclic AMP response element binding proteins: a cornucopia of transcription factors. [review]. Mol. Endocrinol. 4:1087-1094.
11. Hoeffler, J.P., T.E. Meyer, Y. Yun, J.L. Jameson, and J.F. Habener, 1988. Cyclic AMP-responsive DNA-binding protein: structure based on a cloned placental cDNA. Science. 242:1430-1433.
12. Vallejo, M. 1994. Transcriptional control of gene expression by cAMP-response element binding proteins. J. Neuroendocrinol. 6:587-596.
13. Ginty, D.D., A. Bonni, and M.E. Greenberg. 1994. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell. 77:713-725.
14. Barton, K., N. Muthusamy, M. Chanyangam, C. Fischer, C. Clendenin, and J.M. Leiden. 1996. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature. 379: 81-85.
15. Gonzalez, G.A., and M.R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at Serine 133. Cell. 59:675-680.
16. Yamamoto, K.K., G.A. Gonzalez, I.W.H. Biggs, and M.R. Montminy. 1988. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature. 334:494-498.
17. Kwok, R.P., J.R. Lundblad, J.C. Chrivia, J.P. Richards, H.P. Bachinger, R.G. Brennan, S.G. Roberts, M.R. Green, and R.H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370: 223-226.
18. Arias, J., A.S. Alberts, P. Brindle, F.X. Claret, T. Smeal, M. Karin, J. Feramisco, and M. Montminy. 1994. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature. 370:226-229.
19. Chrivia, J.C., R.P. Kwok, N. Lamb, M. Hagiwara, M.R. Montminy, and R.H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature. 365:855-859.
20. Sheng, M., M.A. Thompson, and M.E. Greenberg. 1991. CREB: a Ca2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science. 252:1427-1430.
21. Xing, J., D.D. Ginty, and M.E. Greenberg. 1996. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 273:959-962.
22. Ofir, R., V.J. Dwarki, D. Rashid, and I.M. Verma. 1991. CREB represses transcription of fos promoter: role of phosphorylation. Gene Exp. 1:55-60.
23. Lamph, W.W., V.J. Dwarki, R. Ofir, M. Montminy, and I.M. Verma. 1990. Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation. Proc. Natl. Acad. Sci. USA. 87:4320-4324.
24. Struthers, R.S., W.W. Vale, C. Arias, P.E. Sawchenko, and M.R. Montminy. 1991. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature. 350:622-624.
25. Goldspink, P.H., and B. Russell. 1994. The cAMP response element binding protein is expressed and phosphorylated in cardiac myocytes. Circ. Res. 74:1042-1049.
26. Muller, F.U., P. Boknik, A. Horst, J. Knapp, B. Linck, W. Schmitz, U. Vahlensieck, and A. Walter. 1995. In vivo isoproterenol treatment leads to downregulation of the mRNA encoding the cAMP response element binding protein in the rat heart. Biochem. Biophys. Res. Commun. 215:1043-1049.
27. Muller, F.U., P. Boknik, A. Horst, J. Knapp, B. Linck, W. Schmitz, U. Vahlensieck, M. Bohm, M.C. Deng, and H.H. Scheld. 1995. cAMP response element binding protein is expressed and phosphorylated in human heart. Circulation. 92:2041-2043.
28. Milano, C.A., L.F. Allen, H.A. Rockman, P.C. Dolber, T.R. McMinn, K.R. Chien, T.D. Johnson, R.A. Bond, and R.J. Lefkowitz. 1994. Enhanced myocardial function in transgenic mice overexpressing the Beta2-adrenergic receptor. Science. 264:582-586.
29. Koch, W.J., H.A. Rockman, P. Samama, R. Hamilton, R.A. Bond, C.A. Milano, and R.J. Lefkowitz. 1995. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a BetaARK inhibitor. Science. 268:1350-1353.
30. Bristow, M.R., R. Ginsburg, W. Minobe, R.S. Cubicciotti, W.S. Sageman, K. Lurie, M.E. Billingham, D.C. Harrison, and E.B. Stinson. 1982. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 307:205-211.
31. Bristow, M.R., N.E. Kantrowitz, R. Ginsburg, and M.B. Fowler. 1985. Beta-adrenergic function in heart muscle disease and heart failure. [review]. J. Mol. Cell. Cardiol. 17(Suppl. 2):41-52.
32. Bristow, M.R., R.E. Hershberger, J.D. Port, E.M. Gilbert, A. Sandoval, R. Rasmussen, A.E. Cates, and A.M. Feldman. 1990. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation. 82(Suppl.):I12-I25.
33. Subramaniam, A., W.K. Jones, J. Gulick, S. Wert, J. Neumann, and J. Robbins. 1991. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266:24613-24620.
34. Gulick, J., A. Subramaniam, J. Neumann, and J. Robbins. 1991. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J. Biol. Chem. 266:9180-9185.
35. Palermo, J., J. Gulick, W. Ng, I.L. Grupp, G. Grupp, and J. Robbins. 1995. Remodeling the mammalian heart using transgenesis. Cell. Mol. Biol. Res. 41:501-509.
36. Palermo, J., J. Gulick, M. Colbert, J. Fewell, and J. Robbins. 1996. Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ. Res. 78:504-509.
37. Fentzke, R.C., C.E. Korcarz, S.G. Shroff, H. Lin, J. Sandelski, J.M. Leiden, and R.M. Lang. 1997. Evaluation of ventricular and arterial hemodynamics in anesthetized closed-chest mice. J. Am. Soc. Echocardiogr. 10:915-425.
38. Manning, W.J., J.Y. Wei, S.E. Katz, P.S. Douglas, and J.K. Gwathmey. 1993. Echocardiographically detected myocardial infarction in the mouse. Lab. Anim. Sci. 43:583-585.
39. Hoit, B.D., S.F. Khoury, E.G. Kranias, N. Ball, and R.A. Walsh. 1995. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ. Res. 77:632-637.
40. Gardin, J.M., F.M. Siri, R.N. Kitsis, J.G. Edwards, and L.A. Leinwand. 1995. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ. Res. 76:907-914.
41. Pollick, C., S.L. Hale, and R.A. Kloner. 1995. Echocardiographic and cardiac Doppler assessment of mice. J. Am. Soc. Echocardiogr. 602-610.
42. Edwards, B.S., D.M. Ackermann, M.E. Lee, G.S. Reeder, L.E. Wold, and J.C. Burnett, Jr. 1988. Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure. J. Clin. Invest. 81:82-86.
43. Lattion, A.L., J.B. Michel, E. Arnauld, P. Corvol, and F. Soubrier. 1986. Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am. J. Physiol. 251 (5 Pt 2):H890-H896.
44. Izumo, S., B. Nadal-Ginard, and V. Mahdavi. 1988. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc. Natl. Acad. Sci. USA. 85:339-343.
45. Lompre, A.M., K. Schwartz, A. d'Albis, G. Lacombe, N. Van Thiem, and B. Swynghedauw. 1979. Myosin isoenzyme redistribution in chronic heart overload. Nature. 282:105-107.
46. Izumo, S., A.M. Lompre, R. Matsuoka, G. Koren, K. Schwartz, B. Nadal-Ginard, and V. Mahdavi. 1987. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J. Clin. Invest. 79:970-977.
47. Mercadier, J.J., A.M. Lompre, C. Wisnewsky, J.L. Samuel, J. Bercovici, B. Swynghedauw, and K. Schwartz. 1981. Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ. Res. 49:525-532.
48. Narula, J., N. Haider, R. Virmani, T.G. DiSalvo, F. Kolodgie, R.J. Hajjar, U. Schmidt, M.J. Semigran, G.W. Dec, and B. Khaw. 1996. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335:1182-1189.
49. Yao, M., A. Keogh, P. Spratt, C.G. dos Remedios, and P.C. Kiebling. 1996. Elevated DNase 1 levels in human idiopathic dilated cardiomyopathy: an indicator of apoptosis? J. Mol. Cell. Cardiol. 28:95-101.
50. Sharov, V.G., H.N. Sabbah, H. Shimoyama, A.V. Goussev, M. Lesch, and S. Goldstein. 1996. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am. J. Pathol. 148:141-149.
51. Group, C.T. 1987. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study. N. Engl. J. Med. 316:1429-1435.
52. Cohn, J.N., D.Z. Archibald, S. Ziesche, J.A. Franciosa, W.E. Harston, F.E. Tristani, W.B. Dunkman, W. Jacobs, G.S. Francis, and K.H. Flohr. 1986. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative Study (V-HeFT). N. Engl. J. Med. 314:1547-1552.
53. SOLVD Investigators. 1991. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 325:293-302.
54. Pfeffer, M.A., E. Braunwald, L.A. Moye, L. Basta, J.E.J. Brown, T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, and G.C. Flaker. 1992. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N. Engl. J. Med. 327:669-677.
55. Arber, S., J.J. Hunter, J. Ross, Jr., M. Hongo, G. Sansig, J. Borg, J.C. Perriard, K.R. Chien, and P. Caroni. 1997. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. '88:393-403.
56. Edwards, J.G., G.E. Lyons, B.K. Micales, A. Malhotra, S. Factor, and L.A. Leinwand. 1996. Cardiomyopathy in transgenic myf5 mice. Circ. Res. 78: 379-387.
57. Geisterfer-Lowrance, A.A., M. Christe, D.A. Conner, J.S. Ingwall, F.J. Schoen, C.E. Seidman, and J.G. Seidman. 1996. A. mouse model of familial hypertrophic cardiomyopathy. Science. 272:731-734.
58. Michels, V.V., P.P. Moll, F.A. Miller, J. Tajik, J. Chu, D.J. Driscoll, J.C. Burnett, F.J. Rodeheffer, J.H. Chesebro, and H.D. Tazelaar. 1992. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 326:77-81.
59. Kass, S., C. MacRae, H.L. Graber, E.A. Sparks, D. McNamara, H. Boudoulas, C.T. Basson, I.P.B. Baker, R.J. Cody, and M.C. Fishman. 1994. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat. Genet. 7:546-551.
60. Krajinovic, M., B. Pinamonti, G. Sinagra, M. Vatta, G.M. Severini, J. Milasin, A. Falaschi, F. Camerini, M. Giacca, and L. Mestroni. 1995. Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group. Am. J. Hum. Genet. 57:846-852.
61. Olson, T.M., and M.T. Keating. 1996. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J. Clin. Invest. 97:528-532.
62. Taylor, A.K., I. Klisak, T. Mohandas, R.S. Sparkes, C. Li, R. Gaynor, and A.J. Lusis. 1990. Assignment of the human gene for CREB1 to chromosome 2q32.3-q34. Genomics. 7:416-421.
63. Lerer, C.V. 1992. Current status of non-digitalis positive inotropic drugs. Am. J. Cardiol. 69:120G-128G.
64. Packer, M., J.R. Carver, R.J. Roceheffer, and P.S.R. Group. 1991. Effect of oral milrinone on mortality in severe chronic heart failure. N. Engl. J. Med. 325:1468-1475.
65. Waagstein, F., M.R. Bristow, and K. Swedberg. 1993. Beneficial effects of metroprolol in idiopathic dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation. 342:1441-1446.